Logo
mobilemenu
close
CMN+
Home
Clinical Trials
Diseases
CRISPR&
CRISPR and Acute Myeloid Leukemia
CRISPR and Beta-Thalassemia
CRISPR and Cancer
CRISPR and Diabetes
CRISPR and Duchenne Muscular Dystrophy
CRISPR and Herpes Simplex Virus (HSV)
CRISPR and HIV
CRISPR and Sickle Cell Disease (SCD)
Companies
2seventybio
Acrigen Biosciences
Allife Medical Science And Technology
Allogene Therapeutics
Anhui Kedgene Biotechnology
Anjie Biomedical Technology
Arbor Biotechnologies
ArsenalBio
AstraZeneca
Bayer
Beam Therapeutics
Bioheng Biotech
Biomedrex Genetics
Bluebird Bio
BlueRock Therapeutics
BRAIN Biotech AG
Bristol Myers Squibb
Capsida Biotherapeutics
Cardea Bio
Caribou Biosciences
Cellectis
Celularity
Century Therapeutics
Clade Therapeutics
CRISPR Therapeutics
CRISPR QC
Chroma Medicine
CyGenica
Cytovia Therapeutics
Defence Therapeutics
Demeetra AgBio
EdiGene
Editas Medicine
ElevateBio
Eli Lilly
Eligo Biosciences
Emendo Biotherapeutics
Excision BioTherapeutics
Fate Therapeutics
Gamida Cell
Généthon
GenEdit
Gracell Biotechnologies
Graphite Bio
Hunterian Medicine
iECURE
Inscripta
Iovance Biotherapeutics
Integra Therapeutics
Intellia Therapeutics
Intima Bioscience
Kyverna Therapeutics
Lempo Therapeutics
Ligandal
Life Edit Therapeutics
LogicBio Therapeutics
Locus Biosciences
Mammoth Biosciences
Metagenomi
Moderna
Neukio Biotherapeutics
NKarta Therapeutics
Novartis
Novo Nordisk
ONK Therapeutics
Pfizer
Precision Biosciences
Prime Medicine
Poseida Therapeutics
ProQR Therapeutics
Recombinetics
Refuge Biotechnologies
Regeneron Pharmaceuticals
Sana Biotechnology
Sandhill Therapeutics
Sangamo Therapeutics
Sanofi
Sarepta Therapeutics
Scribe Therapeutics
Servier
Shanghai Bangyao Biotechnology Co., Ltd. - BioRay Laboratories
Shanghai BDgene Technology
Shanghai IASO Biotechnology
Sherlock Biosciences
SNIPR Biome
SparingVision
Spotlight Therapeutics
Takeda Pharmaceuticals
TCR2 Therapeutics
TargetGene Biotechnologies
Tessera Therapeutics
Tmunity Therapeutics
Twelve Bio
Vertex Pharmaceuticals
Verve Therapeutics
Viacyte
Vor Biopharma
Wugen
CMN Jobs
Job Upload Form
CMN Audio
Webinars
CMN Webinars On-demand - All
CMN Webinar - The TCR Therapy Revival
CMN Webinar - Deliver CRISPR to the Brain - A New Treatment Strategy for Mucopolysaccharidoses
CMN Webinar - Controllable Genome Editing With Split-Engineered Base Editors
CMN Webinar - CRISPR-based Control of Insect-borne Diseases
CMN Webinar - CRISPR and MLD
CMN Webinar - CRISPR Off-Targets II
CMN Webinar - Rare Diseases and CRISPR
CMN Webinar - CRISPR On/Off Target
CMN Webinar - CRISPR Off-Targets
CMN Webinar - CRISPR Delivery Systems
CMN Webinar - Certainty After CRISPR
Markets
Newsletter
Advertising
WDC
About
search
Selfservice
|
Subscriberlogin
Logout
Prime Editors
Base Editors
Delivery
Safety
Off-target
Microbiome
CAR-T
TIL
Rare Diseases
Trials
Diagnostics
CMN Weekly
CARBON
Base Editors Clinical Trials
All
|
CRISPR-Cas
|
TALEN
|
ZFN
|
MegaNuclease
|
megaTAL
|
CAS-CLOVER
Antibacterial
Blood
Cancer
Eye
Metabolic disorder
Other genetic conditions
Familial Hypercholesterolemia, FH, (NCT05398029)
Sponsors:
Verve Therapeutics, Inc.,
Indicator
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine
